Kidney Failure And Stroke: Is There A Link?

Chronic kidney disease (CKD) is a risk factor for stroke, with CKD patients having a 5 to 30-fold higher risk of stroke compared to the general population. The risk is particularly high for patients on dialysis, with an 8 to 10-fold increased incidence of stroke. CKD patients with comorbidities such as hypertension and diabetes are at an even higher risk of stroke. The high risk of stroke in CKD patients is due to various factors, including endothelial dysfunction, accelerated atherosclerosis, impaired cerebral autoregulation, and cerebral blood flow dysautoregulation. The management of stroke in CKD patients is challenging due to the interplay between the two conditions, and further research is needed to develop effective preventive strategies.

Patients with CKD have a 5-30 times higher risk of stroke, especially on dialysis

Patients with chronic kidney disease (CKD) have a 5-30 times higher risk of stroke, especially on dialysis. CKD is a well-known risk factor for stroke, which is a leading cause of morbidity and mortality worldwide. The heightened risk of stroke in CKD is due to the interplay of vascular co-morbidities that occur with renal impairment and factors specific to renal failure.

The risk of stroke is influenced by several factors, including old age, hypertension, diabetes, previous cerebrovascular disease, and the use of anticoagulants. CKD patients on dialysis face an even greater risk, with studies reporting an 8-10 times higher incidence of stroke compared to the general population. This elevated risk is further exacerbated during the initiation of dialysis, with stroke rates peaking in the first 30 days.

The management of stroke in CKD patients is challenging and requires a comprehensive approach. While thrombolytic therapy for stroke has shown an increased risk of intracranial hemorrhage, controlling hypertension and the judicious use of antiplatelet agents remain the mainstay of stroke prevention. Additionally, the benefits of statin therapy in dialysis patients as a preventive measure have not been established.

The high risk of stroke in CKD patients, especially those on dialysis, underscores the importance of understanding the underlying factors and implementing effective preventive strategies. Further research and well-designed randomized controlled trials are needed to address this growing concern and improve patient outcomes.

CKD patients with comorbidities like hypertension and diabetes have a higher risk of stroke

The presence of these comorbidities in CKD patients increases the risk of stroke due to the interplay of vascular co-morbidities that occur with renal impairment and factors specific to renal failure. These factors include malnutrition-inflammation-atherosclerosis complex, the effect of uremic toxins, dialysis techniques, vascular access, and the use of anticoagulants to maintain flow in the extracorporeal circuit.

CKD patients with comorbidities like hypertension and diabetes are at a heightened risk of stroke and require careful management to prevent adverse outcomes.

CKD patients have a higher risk of intracerebral haemorrhage and cerebral microbleeds

Chronic kidney disease (CKD) is an independent risk factor for stroke, including both hemorrhagic and ischemic subtypes. CKD patients have a heightened risk for all subtypes of stroke compared to the general population. CKD patients with end-stage kidney disease (ESKD) receiving renal replacement therapy are at a four- to ten-fold higher risk of stroke relative to the general population, and this risk increases seven-fold during the first year of dialysis. CKD patients with ESKD also have significantly poorer functional outcomes and greater mortality after suffering a stroke.

CKD is associated with a higher risk of intracerebral haemorrhage (ICH) and cerebral microbleeds (CMBs). CKD increases the risk of ICH and CMBs, defined as small chronic brain hemorrhages that can act as a nidus for future hemorrhagic events. Among patients with ICH, an eGFR <45 mL/min/1.73 m2 is associated with a three-fold increase in the volume of the hematoma and a four-fold higher risk of death, compared to patients without renal impairment. CKD was found to be independently associated with the presence of any form of CMB and mixed CMBs. Moreover, moderate to severe CKD was independently associated with the presence of multiple CMBs.

CKD patients have a higher risk of cardioembolic, large vessel, and small vessel ischemic stroke

CKD patients are at a heightened risk of cardioembolic, large vessel, and small vessel ischemic stroke. This is due to a multitude of factors, including endothelial dysfunction, accelerated arteriosclerosis, and impaired cerebral autoregulation.

Endothelial dysfunction

Endothelial dysfunction is a common occurrence in CKD patients. It is caused by a variety of factors, including oxidative stress, inflammation, and uremic toxins. Endothelial dysfunction can lead to a pro-thrombotic state, which increases the risk of stroke.

Accelerated arteriosclerosis

CKD patients often have accelerated arteriosclerosis, or a thickening and hardening of the arteries. This can be caused by a variety of factors, including high blood pressure, diabetes, and abnormal cholesterol levels. Accelerated arteriosclerosis can lead to a build-up of plaque in the arteries, which can narrow the arteries and restrict blood flow to the brain, increasing the risk of stroke.

Impaired cerebral autoregulation

Cerebral autoregulation is the brain's ability to maintain a constant blood flow by changing the diameter of blood vessels. CKD patients often have impaired cerebral autoregulation, which can lead to hypoperfusion (too little blood flow) or hyperperfusion (too much blood flow). Both of these conditions can increase the risk of stroke.

CKD patients have a higher risk of stroke before and after dialysis initiation

The risk of stroke in CKD patients is 5-30 times higher than in the general population, with the period of dialysis initiation constituting the highest risk period for developing a new stroke. In an analysis of US dialysis patients aged 67 years and above, stroke rates began to rise about 3 months before dialysis initiation and reached a peak during the first 30 days of dialysis initiation. This pattern was observed irrespective of dialysis modality and whether patients started dialysis in a planned manner.

The risk factors for stroke in CKD patients include old age, hypertension, diabetes, previous cerebrovascular disease, and non-modifiable risk factors such as gender, ethnicity, and family history. Additionally, CKD-specific factors like accelerated atherosclerosis, vascular calcification, prothrombotic tendency, and impaired cerebral autoregulation also contribute to the increased risk of stroke in this population.

The presence of CKD is associated with a higher risk of both ischemic and hemorrhagic stroke, with a greater neurological deficit, poorer functional outcomes, and increased mortality following a stroke. CKD patients on dialysis have a higher risk of stroke compared to those who do not require renal replacement therapy.

The management of stroke in CKD patients includes thrombolytic therapy with recombinant tissue plasminogen activator (rTPA) as the standard of care for patients presenting within 4.5 hours of symptom onset. However, the presence of CKD alone should not be a contraindication to the administration of IV TPA for eligible patients.

To reduce stroke rates in this vulnerable group, preventive strategies need to be better applied. Control of hypertension and the judicious use of antiplatelet agents form the mainstay of stroke prevention in CKD patients. The benefits of antiplatelet therapies and oral anticoagulants must be balanced against the increased risk of bleeding, especially in dialysis cohorts.

Frequently asked questions